Study of Lipid Control in Hyperlipidemic Participants (MK-0653-179)

Organon

Status: Completed

Conditions: Dyslipidemia

Treatments: Drug: Hypolipemics; Behavioral: Lifestyle Changes

Study type: Observational

Funder types: Industry

Identifiers

NCT01436253

0653-179

Details and patient eligibility

About

This study is being done to see whether dietary and medicinal measures compliant with hyperlipidemia treatment guidelines will result in achieving target lipid values and to evaluate the total risk of cardiovascular disease in study participants who have not reached satisfactory lipid levels with their current hypolipemic therapy.

Enrollment: 2,196 patients

Sex: All

Ages: 30+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hyperlipidemic
• On therapy for hyperlipidemia for >=3 months without achieving target lipid values

Exclusion criteria

• Hypersensitivity or intolerance to hypolipemics
• Significant myopathy or rhabdomiolysis probably caused by hypolipemics
• Uncontrolled endocrine or metabolic disease which is known to affect lipid or lipoprotein values (for example, hypothyroidism and hyperthyroidism)

Trial design

2,196 participants in 1 patient group

Croatian participants with hyperlipidemia

Description:

Participants being treated in a physician's office for hyperlipidemia who have not achieved target lipid levels on their current hypolipemic therapy.

Treatment:

Drug: Hypolipemics

Behavioral: Lifestyle Changes